Stem cell transplantation is currently being explored as a therapy for many
neurodegenerative diseases including glaucoma. Cellular therapies have the potential to
provide chronic neuroprotection after a single treatment, and early results have been
encouraging in models of spinal cord injury and Parkinson's disease. Stem cells may prove
ideal for use in such treatments as they can accumulate at sites of injury in the central
nervous system (CNS) and may also offer the possibility of targeted treatment delivery …